ENTITY

OliX Pharmaceuticals (226950 KS)

8
Analysis
Health Care • South Korea
OliX Pharmaceuticals, Inc. operates as a biotechnology and pharmaceutical company. The Company develops ribonucleic acid interference technology, ribonucleic acid interference therapeutics, and pharmaceuticals the treatment of macular degeneration. OliX Pharmaceuticals offers services throughout South Korea.
more
•01 Jun 2026 20:29

OliX Pharm: Capital Raise of 111 Billion Won from Investors Including L'Oreal's Venture Fund

​OliX Pharmaceuticals plans to raise 111 billion won through a third-party allocation for operating funds, with investors including L'Oréal Group's...

Logo
135 Views
Share
•19 Nov 2025 04:47

KOSDAQ150 Index Rebalance: 16 Changes a Side; Fadu a Casualty Yet Again

There are 16 changes a side for the KOSDAQ150 in Dec. The index committee has decided not to add Fadu for yet another review. Short interest is...

Logo
819 Views
Share
•29 Jul 2026 11:58

KRX Short Interest Weekly (Jul 24th): Samsung Elec (PREF), Samsung Electronics, OCI, SK Hynix

We analyzed KRX short interest report for the past week and highlighted short interest changes in Samsung Elec (PREF), Samsung Electronics, OCI, SK...

Logo
124 Views
Share
•08 Jan 2026 10:50

KRX Short Interest Weekly (Jan 2nd): NAVER, Alteogen, Samsung SDI, PEPTRON, LG Energy Solution

We analyzed KRX short interest report for the past week and highlighted short interest changes in NAVER, Alteogen, Samsung SDI, PEPTRON, LG Energy...

Logo
343 Views
Share
•05 Jan 2026 07:05

KRX Foreign Holding Weekly (Jan 2nd): SK Hynix, Samsung Electronics, LG Energy Solution, Kakao

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in SK Hynix, Samsung Electronics, LG Energy...

Logo
344 Views
Share
x